More than 2.5 million patients experience hospital-acquired injuries annually, leading to nearly $12 billion in healthcare costs.
DermaTherapy® is the industry’s first FDA cleared, evidence-based therapeutic silk-like bedding and patient apparel to help to reduce the likelihood of patients developing pressure injuries.
Wound, ostomy, and incontinence treatment can be difficult for patients and families to face. Traditional, abrasive textiles may add to adverse effects by damaging the skin when a patient moves or is moved while lying in bed.
DermaTherapy® was developed to enhance patient- and family-centered care and promote optimal health care outcomes.
The first and only therapeutic linen designed with patients and conditions in mind, DermaTherapy® helps control the microclimate—moisture, friction, and shear—between a patient’s skin and support surfaces, thereby reducing the potential for skin damage.
Innovative solutions are sometimes seen as drivers of increased healthcare costs if they fail to deliver positive outcomes. DermaTherapy® is proven to deliver positive outcomes.
If you’d like more information about our products and services, please contact us.